KR20220122840A - Water-soluble emulsion composition comprising alkaloids - Google Patents
Water-soluble emulsion composition comprising alkaloids Download PDFInfo
- Publication number
- KR20220122840A KR20220122840A KR1020210026166A KR20210026166A KR20220122840A KR 20220122840 A KR20220122840 A KR 20220122840A KR 1020210026166 A KR1020210026166 A KR 1020210026166A KR 20210026166 A KR20210026166 A KR 20210026166A KR 20220122840 A KR20220122840 A KR 20220122840A
- Authority
- KR
- South Korea
- Prior art keywords
- water
- weight
- emulsion
- soluble
- alkaloid
- Prior art date
Links
- 239000000839 emulsion Substances 0.000 title claims abstract description 118
- 229930013930 alkaloid Natural products 0.000 title claims abstract description 61
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 56
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 49
- 239000004094 surface-active agent Substances 0.000 claims description 58
- 150000003797 alkaloid derivatives Chemical class 0.000 claims description 49
- 235000006708 antioxidants Nutrition 0.000 claims description 47
- -1 glycerin fatty acid ester Chemical class 0.000 claims description 24
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 21
- 229930195729 fatty acid Natural products 0.000 claims description 21
- 239000000194 fatty acid Substances 0.000 claims description 21
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 14
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 14
- 239000011732 tocopherol Substances 0.000 claims description 13
- 235000010384 tocopherol Nutrition 0.000 claims description 13
- 229930003799 tocopherol Natural products 0.000 claims description 13
- 229960001295 tocopherol Drugs 0.000 claims description 13
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 12
- 235000005487 catechin Nutrition 0.000 claims description 12
- 235000011187 glycerol Nutrition 0.000 claims description 12
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 11
- 229950001002 cianidanol Drugs 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 10
- 239000008157 edible vegetable oil Substances 0.000 claims description 9
- 229960002504 capsaicin Drugs 0.000 claims description 7
- 235000017663 capsaicin Nutrition 0.000 claims description 7
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 claims description 7
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 claims description 7
- 229940075559 piperine Drugs 0.000 claims description 7
- 235000019100 piperine Nutrition 0.000 claims description 7
- 239000004064 cosurfactant Substances 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 235000019198 oils Nutrition 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 4
- 235000019482 Palm oil Nutrition 0.000 claims description 4
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 4
- 239000000787 lecithin Substances 0.000 claims description 4
- 235000010445 lecithin Nutrition 0.000 claims description 4
- 229940067606 lecithin Drugs 0.000 claims description 4
- 239000002540 palm oil Substances 0.000 claims description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- 235000019774 Rice Bran oil Nutrition 0.000 claims description 2
- 235000019485 Safflower oil Nutrition 0.000 claims description 2
- 235000019486 Sunflower oil Nutrition 0.000 claims description 2
- 235000005687 corn oil Nutrition 0.000 claims description 2
- 239000002285 corn oil Substances 0.000 claims description 2
- 239000001087 glyceryl triacetate Substances 0.000 claims description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920000223 polyglycerol Polymers 0.000 claims description 2
- 239000008165 rice bran oil Substances 0.000 claims description 2
- 235000005713 safflower oil Nutrition 0.000 claims description 2
- 239000003813 safflower oil Substances 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 239000002600 sunflower oil Substances 0.000 claims description 2
- 229960002622 triacetin Drugs 0.000 claims description 2
- 239000010497 wheat germ oil Substances 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims 1
- 235000013322 soy milk Nutrition 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 29
- 230000003647 oxidation Effects 0.000 abstract description 9
- 238000007254 oxidation reaction Methods 0.000 abstract description 9
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 5
- 239000001301 oxygen Substances 0.000 abstract description 5
- 229910052760 oxygen Inorganic materials 0.000 abstract description 5
- 239000007864 aqueous solution Substances 0.000 abstract description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 4
- 239000008204 material by function Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 87
- 230000000052 comparative effect Effects 0.000 description 60
- 239000002245 particle Substances 0.000 description 16
- 238000004945 emulsification Methods 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 238000001159 Fisher's combined probability test Methods 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0053—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/01—Other fatty acid esters, e.g. phosphatides
- A23D7/011—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
- A23D9/013—Other fatty acid esters, e.g. phosphatides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/06—Preservation of finished products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L35/00—Food or foodstuffs not provided for in groups A23L5/00 – A23L33/00; Preparation or treatment thereof
- A23L35/10—Emulsified foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/20—Ingredients acting on or related to the structure
- A23V2200/222—Emulsifier
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/712—Vitamin E
Abstract
Description
본 발명은 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물에 관한 것이다. The present invention relates to an alkaloid-containing water-soluble emulsion composition containing a water-soluble antioxidant emulsion.
알칼로이드(alkaloids)는 질소를 포함하고 있는 염기성 화합물로써 비교적 소량으로 사람과 동물에 강한 약리작용을 나타내는 유기 화합물의 총칭이며, 사람과 동물에게 특이적이고 강한 생리작용을 주는 특성이 있어 의약품으로 주로 이용된다.Alkaloids are basic compounds containing nitrogen, and are a generic term for organic compounds that exhibit strong pharmacological effects on humans and animals in relatively small amounts. .
알칼로이드를 다량 함유한 식물은 대부분 약초로 알려져 있으며 주로 열대 또는 아열대 식물이 많고 이러한 알칼로이드에는 약리작용과 함께 독성작용도 있어 상용하면 중독증상을 일으킬 수 있으므로, 의약품이 아닌 자연적으로 존재하는 알칼로이드 고 함유 식품을 섭취할 때는 주의가 필요하다. Most of the plants containing a large amount of alkaloids are known as medicinal herbs, and there are mainly tropical or subtropical plants. These alkaloids also have pharmacological and toxic effects. Caution is required when consuming.
이와 같은 알칼로이드를 비롯한 기능성 천연물들은 대부분 수난용성이며 체내흡수성이 매우 낮아 생체 이용률이 떨어지는 문제점이 있다. 따라서 이들이 갖는 생리활성물질을 활용한 식품, 의약품, 사료 등의 적용에 제한점이 있다. 또한 기존의 수용화된 기능성 유화물들은 O/W형의 유화물로 수상인 물과 물에 함유되어 산소에 의해서 산화되어 항산화 효능을 소실하거나 산패되는 문제점을 가지고 있다. Functional natural products, including such alkaloids, are mostly poorly soluble in water and have very low bioavailability due to very low body absorption. Therefore, there is a limit to the application of food, medicine, feed, etc. utilizing their physiologically active substances. In addition, the existing water-soluble functional emulsions are O/W type emulsions, which are contained in water and water, which are aqueous phases, and are oxidized by oxygen to lose antioxidant efficacy or to go rancid.
한편, α-Tocopherol은 대표적인 천연 항산화제로써 종자유(Seed oil)나 곡류 그리고 녹색 잎을 갖는 야채에 많이 분포되어 있으며, 비타민 E로써 세포막에 존재하는 주요한 지용성의 항산화제이며, 지방의 산화를 막아준다. 비타민 E는 퍼옥시 라디칼(ROO·), CCl3, HO· 포함하는 다양한 산소 라디칼뿐만 아니라 수퍼옥사이드 라디칼(O2·)과 직접 반응할 수 있다. 항산화력은 δ > γ > β> α 순으로 높다. 작용기작으로 세포막을 구성하는 다가불포화지방산은 세포에서 만들어진 자유라디칼에 의해 쉽게 산화되는데, 토코페롤은 이러한 산화과정을 중단시키고 자유라디칼을 제거해 세포막을 산화적 손상으로부터 보호해준다. On the other hand, α-Tocopherol is a representative natural antioxidant, widely distributed in seed oil, grains, and vegetables with green leaves. As vitamin E, it is a major fat-soluble antioxidant present in cell membranes and prevents oxidation of fat. . Vitamin E can react directly with various oxygen radicals including peroxy radicals (ROO·), CCl 3 , HO· as well as superoxide radicals (O 2 ·). The antioxidant power is high in the order of δ > γ > β > α. As a mechanism of action, polyunsaturated fatty acids composing cell membranes are easily oxidized by free radicals made in cells. Tocopherol stops this oxidation process and removes free radicals to protect cell membranes from oxidative damage.
본 발명의 과제는 기능성 난용성 물질을 수용화 시켜 물질의 흡수율과 효능을 증대시킬 수 있을 뿐만 아니라 수용액 상에서 산화 안정성이 우수한 알칼로이드 함유 수용성 유화 조성물을 제공하는 것이다. An object of the present invention is to provide an alkaloid-containing water-soluble emulsion composition that not only can water-soluble functionally poorly soluble substances to increase the absorption rate and efficacy of substances, but also has excellent oxidative stability in aqueous solution.
상기한 과제를 달성하기 위해 본 발명은 In order to achieve the above object, the present invention
(1) 전체 100 중량%를 만족하도록 하기 성분을 포함하는 수용성 항산화제 유화물: (1) A water-soluble antioxidant emulsion comprising the following ingredients to satisfy 100% by weight of the total:
토코페롤 1 내지 40 중량%,1 to 40% by weight of tocopherol,
카테킨 1 내지 40 중량%,1 to 40% by weight of catechin,
HLB 3 내지 HLB 7의 제1 계면활성제 1 내지 30 중량%,1 to 30% by weight of a first surfactant of HLB 3 to HLB 7,
HLB 10 내지 HLB 14의 제2 계면활성제 10 내지 80 중량%;10 to 80% by weight of a second surfactant of HLB 10 to HLB 14;
공계면활성제 10 내지 45 중량%, 및10 to 45% by weight of a cosurfactant, and
식용 유지 1 내지 35 중량%,1 to 35% by weight of edible oil,
(2) 전체 100 중량%를 만족하도록 하기 성분을 포함하는 알칼로이드 유화물:(2) an alkaloid emulsion comprising the following components to satisfy the total 100% by weight:
알칼로이드 1 내지 30 중량%,1 to 30% by weight of an alkaloid;
HLB 3 내지 HLB 7의 제1 계면활성제 1 내지 10 중량%,1 to 10% by weight of a first surfactant of HLB 3 to HLB 7,
HLB 10 내지 HLB 14의 제2 계면활성제 1 내지 20 중량%, 및1 to 20% by weight of a second surfactant of HLB 10 to HLB 14, and
공계면활성제 40 내지 97 중량%, 40 to 97% by weight of co-surfactant,
를 포함하는, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물을 제공한다. It provides an alkaloid-containing water-soluble emulsion composition comprising a water-soluble antioxidant emulsion.
본 발명의 일 구현예에 따른 알칼로이드 함유 수용성 유화 조성물은 기능성 수난용 물질을 수용화 시킴으로써 물질의 흡수율과 효능을 증대시킬 수 있어, 물질이 갖는 기능성을 다양한 분야에 활용될 수 있도록 한다.The water-soluble emulsion composition containing an alkaloid according to an embodiment of the present invention can increase the absorption rate and efficacy of the material by making the functional material for poor water solubility in water, so that the functionality of the material can be utilized in various fields.
또한, 수용성 항산화제 유화물을 함유하여, 수용액 상에서 산소에 의한 산화를 예방할 수 있는 산화 안정성이 우수하다. In addition, since it contains a water-soluble antioxidant emulsion, it has excellent oxidation stability that can prevent oxidation by oxygen in aqueous solution.
도 1은 비교예 33의 알칼로이드 함유 수용성 유화 조성물의 유화 입자를 광학현미경으로 관찰한 사진이다.
도 2는 실시예 1의 알칼로이드 함유 수용성 유화 조성물의 유화 입자를 광학현미경으로 관찰한 사진이다. 1 is a photograph of observation of emulsified particles of an alkaloid-containing water-soluble emulsion composition of Comparative Example 33 under an optical microscope.
2 is a photograph of the emulsified particles of the alkaloid-containing water-soluble emulsion composition of Example 1 observed under an optical microscope.
이하 본 발명의 일 구현예에 따른 수용성 항산화 유화물과 알칼로이드 유화물을 상세히 설명한다. Hereinafter, a water-soluble antioxidant emulsion and an alkaloid emulsion according to an embodiment of the present invention will be described in detail.
본 발명의 일 구현예에 따른 알칼로이드 함유 수용성 유화 조성물은 수용성 항산화 유화물과 알칼로이드 유화물을 포함한다. An alkaloid-containing water-soluble emulsion composition according to an embodiment of the present invention includes a water-soluble antioxidant emulsion and an alkaloid emulsion.
상기 수용성 항산화제 유화물은 전체 100 중량%를 만족하도록, 토코페롤 1 내지 40 중량%, 카테킨 1 내지 40 중량%, HLB 3 내지 HLB 7의 제1 계면활성제 1 내지 30 중량%, HLB 10 내지 HLB 14의 제2 계면활성제 10 내지 80 중량%, 공계면활성제 10 내지 45 중량%, 및 식용 유지 1 내지 35 중량%를 포함한다. The water-soluble antioxidant emulsion is 1 to 40% by weight of tocopherol, 1 to 40% by weight of catechin, 1 to 30% by weight of the first surfactant of HLB 3 to HLB 7, HLB 10 to HLB 14 to satisfy 100% by weight of the total 10 to 80% by weight of a second surfactant, 10 to 45% by weight of a cosurfactant, and 1 to 35% by weight of an edible oil and fat.
상기 토코페롤과 카테킨은 각각 지용성, 수용성 항산화제로서 유화물 내에 포함된다. 이때 토코페롤과 카테킨의 함량이 상기 범위 미만이면 첨가에 따른 항산화 효과가 미미하고, 이와 반대로 상기 범위를 초과하면 유화물의 유화 안정성이 현저히 저하되는 문제점이 있다. The tocopherol and catechin are included in the emulsion as fat-soluble and water-soluble antioxidants, respectively. At this time, if the content of tocopherol and catechin is less than the above range, the antioxidant effect is insignificant when added.
상기 HLB(Hydrophile-Lipophile Balance)는 계면활성제가 물과 기름에 대한 친화성 정도를 나타내는 값이며, HLB는 그 값이 작을수록 분자 전체로서 친유성이 강하고, 그 값이 커질수록 친수성이 강한 것을 나타낸다. The HLB (Hydrophile-Lipophile Balance) is a value indicating the affinity of the surfactant to water and oil, and HLB indicates that the smaller the value, the stronger the lipophilicity as a whole molecule, and the larger the value, the stronger the hydrophilicity. .
상기 수용성 항산화 유화물과 알칼로이드 유화물은 각 유화물의 유화 안정성을 확보하고, 친수성 공계면활성제 내에 잘 녹으면서 계면활성 효과를 나타내기 위한 측면에서 HLB(Hydrophile-Lipophile Balance)가 상이한 2종의 계면활성제를 포함한다. The water-soluble antioxidant emulsion and the alkaloid emulsion include two surfactants with different HLB (Hydrophile-Lipophile Balance) in terms of securing the emulsion stability of each emulsion, and exhibiting the surfactant effect while being well soluble in the hydrophilic co-surfactant. do.
상기 제1 계면활성제는 HLB가 3 내지 7인 것을 사용하고, 제2 계면활성제는 HLB가 10 내지 14인 것을 사용하는 것이 유화 입자 간 응집을 방지하고, 친수성 공계면활성제와 식용 유지 내에서 항산화제인 토코페롤과 카테킨이 각각의 항산화력을 유지하기 위한 측면에서 더욱 효과적이다. 상기 제1 계면활성제의 HLB가 3 미만인 경우 에멀젼이 잘 형성되지 않으며, HLB가 7을 초과하는 경우 입자 간 응집이 발생하여 유화 안정성이 저하된다. 상기 제2 계면활성제의 HLB가 10 미만인 경우 유화가 어렵고, 반대로 HLB 14를 초과하는 경우 유화 안정성이 떨어진다. The first surfactant uses a HLB of 3 to 7, and the second surfactant uses a HLB of 10 to 14 to prevent aggregation between the emulsified particles, and is an antioxidant in the hydrophilic co-surfactant and edible oil. Tocopherol and catechin are more effective in terms of maintaining their respective antioxidant powers. When the HLB of the first surfactant is less than 3, the emulsion is not well formed, and when the HLB exceeds 7, agglomeration between particles occurs and the emulsion stability is lowered. When the HLB of the second surfactant is less than 10, it is difficult to emulsify, and on the contrary, when the HLB exceeds 14, the emulsion stability is deteriorated.
상기 HLB 3 내지 HLB 7의 제1 계면활성제는 공지된 것이라면 제한 없이 사용할 수 있으며, 예컨대 글리세린 지방산 에스테르, 폴리글리세린 지방산 에스테르, 솔비탄 지방 에스테르, 레시틴, 프로필렌글리콜 지방산 에스테르 및 이들의 혼합물로 이루어진 군에서 선택된 1종이 가능하다. 이때 제1 계면활성제의 함량은 수용성 항산화제 유화물 전체 중량에 대해 1 내지 30 중량%이다. 제1 계면활성제의 함량이 상기 범위 미만이면 식용 유지의 유화 입자에 대한 유화 작용이 약화되어 에멀젼 형성이 어렵고, 상기 범위를 초과하면 유화 안정성이 떨어지는 문제점이 있다. The first surfactants of HLB 3 to HLB 7 may be used without limitation as long as they are known, for example, from the group consisting of glycerin fatty acid esters, polyglycerol fatty acid esters, sorbitan fatty esters, lecithin, propylene glycol fatty acid esters, and mixtures thereof. Only one selected type is possible. At this time, the content of the first surfactant is 1 to 30% by weight based on the total weight of the water-soluble antioxidant emulsion. If the content of the first surfactant is less than the above range, the emulsification action on the emulsified particles of the edible oil is weakened, making it difficult to form an emulsion.
상기 HLB 10 내지 HLB 14의 제2 계면활성제는 폴리글리세린 지방산 에스테르, 폴리옥시에틸렌 솔비탄 지방산 에스테르, 자당 지방산 에스테르, 효소분해 레시틴 및 이들의 혼합물로 이루어진 군에서 선택된 1종이 가능하나, 이에 한정되는 것은 아니다. 상기 제2 계면활성제의 함량이 상기 수치 범위를 만족하는 경우, 토코페롤과 카테킨의 항산화능을 해하지 않으면서, 수용성 항산화제 유화물 내에 토코페롤과 카테킨이 안정적으로 분산될 수 있도록 한다. The second surfactant of HLB 10 to HLB 14 may be one selected from the group consisting of polyglycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, enzymatically decomposed lecithin, and mixtures thereof, but is limited thereto not. When the content of the second surfactant satisfies the above numerical range, the tocopherol and catechin can be stably dispersed in the water-soluble antioxidant emulsion without impairing the antioxidant ability of tocopherol and catechin.
상기 공계면활성제는 유화에 보조적인 역할을 할 뿐만 아니라 용해제로 사용된다. 상기 공계면활성제는 글리세린, 솔비톨, 폴리에틸렌글리콜, 프로필렌글리콜, 트리아세틴 및 이들의 혼합물로 이루어진 군에서 선택된 1종이 가능하나, 이에 한정되는 것은 아니다. 이러한 공계면활성제의 함량은 수용성 항산화제 유화물 총 중량 대비 10 내지 45 중량%인 것이 바람직하다. 공계면활성제 함량이 10 중량% 미만이면 카테킨을 용해시키는 것이 용이하지 않으며, 45 중량%를 초과하여 사용하면 유화 입자가 잘 형성되지 않고 유화 안정성이 저하되는 문제가 있다. The cosurfactant is used as a solubilizer as well as an auxiliary role in emulsification. The co-surfactant may be one selected from the group consisting of glycerin, sorbitol, polyethylene glycol, propylene glycol, triacetin, and mixtures thereof, but is not limited thereto. The content of the co-surfactant is preferably 10 to 45% by weight based on the total weight of the water-soluble antioxidant emulsion. If the content of the co-surfactant is less than 10% by weight, it is not easy to dissolve the catechin, and when it is used in excess of 45% by weight, there is a problem in that emulsified particles are not well formed and the emulsion stability is lowered.
상기 식용 유지는 식물 또는 동물로부터 얻은 원유나 이를 원료로 하여 제조, 가공한 것이라면 제한 없이 사용 가능하다. 예컨대, 대두유, 옥수수유, 채종유, 고올레산 채종유, 홍화유, 미강유, 팜유, 올리브유, 해바라기유, 야자유, 소맥 배아유, 중쇄중성지방(MCT Oil)에서 선택된 1종 이상의 유지가 가능하다. 이러한 식용 유지의 함량은 조성물 총 중량에 대해 1 내지 35 중량%일 수 있다. 1 중량% 미만에서는 오일의 양이 너무 적어 토코페롤의 용해가 어렵고, 35 중량%를 초과하면 에멀젼의 경시 안정성이 불량하다. The edible oil can be used without limitation as long as it is manufactured or processed by using crude oil obtained from plants or animals or using it as a raw material. For example, one or more oils selected from soybean oil, corn oil, rapeseed oil, high oleic rapeseed oil, safflower oil, rice bran oil, palm oil, olive oil, sunflower oil, palm oil, wheat germ oil, and medium chain triglycerides (MCT Oil) are possible. The content of such edible oils and fats may be 1 to 35% by weight based on the total weight of the composition. If it is less than 1% by weight, the amount of oil is too small to dissolve the tocopherol, and if it exceeds 35% by weight, the stability over time of the emulsion is poor.
상기 알칼로이드 유화물은 전체 100 중량%를 만족하도록, 알칼로이드 1 내지 30 중량%, HLB 3 내지 HLB 7의 유중 수적형 계면활성제 1 내지 10 중량%, HLB 10 내지 HLB 14의 수중 유적형 계면활성제 1 내지 20 중량%, 및 공계면활성제 40 내지 97 중량%를 포함한다. The alkaloid emulsion contains 1 to 30% by weight of alkaloids, 1 to 10% by weight of a water-in-oil surfactant of HLB 3 to HLB 7, and 1 to 20% by weight of an oil-in-water surfactant of HLB 10 to HLB 14 so as to satisfy 100% by weight of the total. % by weight, and 40 to 97% by weight of a cosurfactant.
상기 알칼로이드는 경구 투여시 포유동물에서 생물학적인 영향을 미치는 것은 제한 없이 사용할 수 있다. 일 예로, 피페린, 캡사이신이다. The alkaloid may be used without limitation if it has a biological effect on a mammal when administered orally. For example, piperine, capsaicin.
이러한 알칼로이드는 알칼로이드 유화물 전체 중량에 대해 1 내지 30 중량%로 포함된다. 만약 알칼로이드의 함량이 상기 범위 미만이면 첨가에 따른 효과가 미미하고, 30 중량%를 초과하면 유화 입자 형성이 어려운 문제점이 있다. These alkaloids are included in an amount of 1 to 30% by weight based on the total weight of the alkaloid emulsion. If the content of the alkaloid is less than the above range, the effect of the addition is insignificant, and if it exceeds 30 wt%, it is difficult to form emulsified particles.
알칼로이드 유화물은 친수성 공계면활성제 내에 잘 녹으면서 계면활성 효과를 나타내어 유화 조성물의 유화 안정성을 유지하기 위해 상기한 HLB 값을 갖는 제1 계면활성제와 제2 계면활성제를 포함한다.The alkaloid emulsion comprises a first surfactant and a second surfactant having the above-described HLB value in order to maintain the emulsion stability of the emulsion composition by exhibiting a surfactant effect while being well soluble in the hydrophilic co-surfactant.
HLB가 3 내지 7인 제1 계면활성제는 알칼로이드 유화물 전체 중량에 대해 1 내지 10 중량%로 포함된다. 제1 계면활성제의 함량이 1 중량% 미만이면 알칼로이드 유화 입자에 대한 유화 작용이 약화되어 에멀젼 형성이 어려운 문제점이 있고, 10 중량%를 초과하면 유화 안정성이 저하되는 문제점이 있다. The first surfactant having an HLB of 3 to 7 is included in an amount of 1 to 10% by weight based on the total weight of the alkaloid emulsion. When the content of the first surfactant is less than 1% by weight, the emulsification action on the alkaloid emulsified particles is weakened, so that it is difficult to form an emulsion, and when it exceeds 10% by weight, there is a problem in that the emulsion stability is lowered.
HLB가 10 내지 14인 제2 계면활성제는 알칼로이드 유화물 전체 중량에 대해 1 내지 20 중량%로 함유된다. 이때 제2 계면활성제의 함량이 1 중량% 미만이면 친수성 공계면활성제에 대한 유화 작용이 약화되어 유화가 어렵고, 20 중량%를 초과하면 유화 안정성을 유지가 어려운 문제점이 있다. The second surfactant having an HLB of 10 to 14 is contained in an amount of 1 to 20% by weight based on the total weight of the alkaloid emulsion. In this case, if the content of the second surfactant is less than 1% by weight, the emulsification action on the hydrophilic co-surfactant is weakened, so that it is difficult to emulsify, and if it exceeds 20% by weight, it is difficult to maintain emulsion stability.
제1 계면활성제와 제2 계면활성제의 구체적인 종류는 상기에서 언급한 바를 따른다. Specific types of the first surfactant and the second surfactant are as described above.
상기 공계면활성제는 알칼로이드를 분산, 용해시키고, 유화에 보조적인 역할을 하기 위해 첨가되는 것으로, 알칼로이드 유화물 중 그 함량은 40 내지 97 중량%이다. 40 중량% 미만에서는 유화 안정성 유지가 어렵고, 97 중량%를 초과하면 알칼로이드의 안정적인 분산이 어렵다. The cosurfactant is added to disperse and dissolve the alkaloid, and to play an auxiliary role in emulsification, and the content of the alkaloid emulsion is 40 to 97 wt%. If it is less than 40% by weight, it is difficult to maintain emulsion stability, and if it exceeds 97% by weight, it is difficult to stably disperse the alkaloid.
상기 알칼로이드 함유 수용성 유화 조성물은 상기 수용성 항산화제 유화물 0.1 내지 20 중량%; 및 상기 알칼로이드 유화물 80 내지 99.9 중량%를 포함한다. The alkaloid-containing water-soluble emulsion composition comprises 0.1 to 20% by weight of the water-soluble antioxidant emulsion; and 80 to 99.9 wt% of the alkaloid emulsion.
본 발명의 알칼로이드 함유 수용성 유화 조성물은 기능성 수난용 물질인 알칼로이드를 수용화 시킴으로써 물질의 흡수율과 효능을 증대시킬 수 있어, 물질이 갖는 기능성을 다양한 분야에 활용될 수 있도록 한다. 또한, 수용성 항산화제 유화물을 함유하여, 수용액 상에서 산소에 의한 산화를 예방할 수 있는 산화 안정성이 우수하다. The water-soluble emulsion composition containing alkaloids of the present invention can increase the absorption rate and efficacy of substances by soluble in alkaloids, which are functional substances for poor water use, so that the functional properties of substances can be utilized in various fields. In addition, since it contains a water-soluble antioxidant emulsion, it has excellent oxidation stability that can prevent oxidation by oxygen in aqueous solution.
이하 본 발명을 실시예를 통해 상세히 설명한다. 그러나 이러한 실시예들로 본 발명의 범위를 한정하는 것은 아니다.Hereinafter, the present invention will be described in detail through examples. However, these examples do not limit the scope of the present invention.
실시예Example
하기 표 1 내지 표 9의 조성으로 각각 수용성 항산화제 유화물과 알칼로이드 유화물을 제조한 후 최종 알칼로이드 함유 수용성 유화 조성물을 제조하였다. After preparing a water-soluble antioxidant emulsion and an alkaloid emulsion, respectively, with the compositions shown in Tables 1 to 9 below, a final alkaloid-containing water-soluble emulsion composition was prepared.
(HLB: 4)glycerin fatty acid esters
(HLB: 4)
(HLB: 2)sucrose fatty acid esters
(HLB: 2)
(HLB: 8)Polyglyceryl-6 diisostearate
(HLB: 8)
(HLB:12)polyglycerin fatty acid esters
(HLB:12)
(HLB: 8)Polyglyceryl-6 diisostearate
(HLB: 8)
(HLB: 18)PEG-18 Stearate
(HLB: 18)
제1계면활성제, 제2계면활성제를 호모 믹서에 투입한 후, 온도를 50 ℃ 이상으로 유지하면서 500 rpm 이하로 교반하였다. 이후 카테킨, 대두유, 토코페롤을 순차적으로 투입하여 원료 1을 제조하였다. After putting the first surfactant and the second surfactant in a homomixer, the mixture was stirred at 500 rpm or less while maintaining the temperature at 50° C. or higher. Thereafter, raw material 1 was prepared by sequentially adding catechin, soybean oil, and tocopherol.
이와는 별도로 글리세린에 제2계면활성제를 투입하여 원료 2를 제조하였다.Separately, raw material 2 was prepared by adding a second surfactant to glycerin.
이때 제2계면활성제는 원료 1과 원료 2에 총 사용량 중 30 중량%와 70 중량%를 각각 사용하였다. At this time, as the second surfactant, 30 wt% and 70 wt% of the total amount of the raw material 1 and 2 were used, respectively.
원료 2에 원료 1을 혼합하면서 호모믹서로 5,000 rpm 이상으로 유화 분산을 진행하여 수용성 항산화제 유화물을 제조하였다. While mixing the raw material 1 with the raw material 2, emulsification and dispersion were carried out at 5,000 rpm or more with a homomixer to prepare a water-soluble antioxidant emulsion.
(HLB:4)glycerin fatty acid esters
(HLB:4)
(HLB: 2)sucrose fatty acid esters
(HLB: 2)
(HLB: 8)Polyglyceryl-6 diisostearate
(HLB: 8)
(HLB: 12)polyglycerin fatty acid esters
(HLB: 12)
(HLB: 8)Polyglyceryl-6 diisostearate
(HLB: 8)
(HLB: 18)PEG-18 Stearate
(HLB: 18)
(HLB:4)glycerin fatty acid esters
(HLB:4)
(HLB: 2)sucrose fatty acid esters
(HLB: 2)
(HLB: 8)Polyglyceryl-6 diisostearate
(HLB: 8)
(HLB: 12)polyglycerin fatty acid esters
(HLB: 12)
(HLB: 8)Polyglyceryl-6 diisostearate
(HLB: 8)
(HLB: 18)PEG-18 Stearate
(HLB: 18)
제1계면활성제, 제2계면활성제를 호모 믹서에 투입한 후, 온도를 50도 이상으로 유지하면서 500 rpm 이하로 교반하였다. 이후 엑다이손 원료를 투입하고 엑타이손이 유화물에 습윤되기 시작하면, 호모믹서의 교반을 시작하여 서서히 rpm을 올리면서 5,000 rpm 이상에서 유화 분산을 진행하였다. 유화가 완료되면 글리세린을 투입한 후 500 rpm 이하에서 교반하여 엑다이손 유화물을 제조하였다.After adding the first surfactant and the second surfactant to the homomixer, the mixture was stirred at 500 rpm or less while maintaining the temperature at 50°C or higher. After that, when the ecdysone raw material was added and the ectysone started to wet the emulsion, the homomixer was stirred and the rpm was gradually increased while emulsifying and dispersing at 5,000 rpm or higher. After the emulsification was completed, glycerin was added and stirred at 500 rpm or less to prepare an ecdysone emulsion.
(중량%)division
(weight%)
(1 중량%)
Preparation Example 1
(1% by weight)
( 10 중량%)Preparation Example 1
(10% by weight)
(1 중량%)Preparation 3
(1% by weight)
(10 중량%)Preparation 3
(10% by weight)
(1 중량%)Preparation 4
(1% by weight)
(10 중량%)Preparation 4
(10% by weight)
(99 중량%)Preparation 9
(99% by weight)
(90 중량%)Preparation 9
(90% by weight)
(99 중량%)Preparation 9
(99% by weight)
(90 중량%)Preparation 9
(90% by weight)
(99 중량%)Preparation 9
(99% by weight)
(90 중량%)Preparation 9
(90% by weight)
(중량%)division
(weight%)
(1 중량%)
Preparation Example 1
(1% by weight)
( 10 중량%)Preparation Example 1
(10% by weight)
(1 중량%)Preparation 3
(1% by weight)
(10 중량%)Preparation 3
(10% by weight)
(1 중량%)Preparation 4
(1% by weight)
(10 중량%)Preparation 4
(10% by weight)
(99 중량%)Preparation 15
(99% by weight)
(90 중량%)Preparation 15
(90% by weight)
(99 중량%)Preparation 15
(99% by weight)
(90 중량%)Preparation 15
(90% by weight)
(99 중량%)Preparation 15
(99% by weight)
(90 중량%)Preparation 15
(90% by weight)
상기 표 10 내지 표 17에 기재된 조성에 따라 이렇게 얻은 알칼로이드 유화물에 상기에서 제조된 수용성 항산화제 유화물을 투입한 후 유화액의 성상을 확인하면서 500 rpm 이하에서 혼합 분산 작업을 진행하여 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물을 제조하였다. After adding the water-soluble antioxidant emulsion prepared above to the alkaloid emulsion thus obtained according to the compositions shown in Tables 10 to 17, mixing and dispersing at 500 rpm or less while checking the properties of the emulsion to contain the water-soluble antioxidant emulsion An alkaloid-containing water-soluble emulsion composition was prepared.
실험예 1: 항산화 효과 측정 Experimental Example 1: Measurement of antioxidant effect
DPPH 측정법을 이용하여 수용성 항산화제 유화물을 포함하는 알칼로이드 함유 수용성 유화 조성물의 항산화 효과를 측정하였다. The antioxidant effect of the alkaloid-containing water-soluble emulsion composition including the water-soluble antioxidant emulsion was measured using the DPPH measurement method.
DPPH 라디칼 소거 활성 측정은 항산화능을 측정하는데 가장 보편적으로 사용되는 방법으로 색상 변화로 항산화능을 평가하는 방법으로, 항산화능이 뛰어난 시료를 처리하면 색의 변화가 뚜렷하고 효과가 떨어지는 시료를 처리하면 보라색에서 많은 변화가 일어나지 않아서 이러한 변화 정도를 spectrophotometer(517nm)로 흡광도를 측정하여 항산화능을 비교하며, 값이 높을수록 항산화 효과도 높다고 평가한다. 실험조건(가혹조건 시험: 40℃에서 1주일간 방치하여 산화 유도)은 아래와 같다. Measurement of DPPH radical scavenging activity is the most commonly used method to measure antioxidant activity. It is a method to evaluate antioxidant activity by color change. When a sample with excellent antioxidant activity is treated, the color change is clear, and when a sample with low effect is treated, the color change is clear. Since many changes do not occur, the absorbance is measured with a spectrophotometer (517nm) to compare the antioxidant capacity, and the higher the value, the higher the antioxidant effect is evaluated. Experimental conditions (severe condition test: oxidation induced by leaving at 40°C for 1 week) are as follows.
① 용매 - 에탄올① Solvent - Ethanol
② 함량 - 0.01 wt% 분산액, 0.02 wt% 분산액② Content - 0.01 wt% dispersion, 0.02 wt% dispersion
③ 방법 - shaking waterbath 사용. 30℃, 2hr③ Method - Use a shaking water bath. 30℃, 2hr
④ 필터 - No.5 여과지 사용 자연여과후 0.45μm 카트리지 필터 사용④ Filter - Use No.5 filter paper, use 0.45μm cartridge filter after natural filtration
실험 결과는 아래 표 6 및 표 7에 나타내었다. The experimental results are shown in Tables 6 and 7 below.
상기 표 6 및 표 7에 나타낸 바와 같이, 수용성 항산화 유화물에 카테킨이나 토코페롤을 포함하지 않은 제조예 3, 제조예 4의 수용성 항산화 유화물을 사용하는 경우 알칼로이드 함유 수용성 유화 조성물의 항산화 효과가 낮은 것을 확인할 수 있었다. As shown in Tables 6 and 7, when the water-soluble antioxidant emulsions of Preparation Examples 3 and 4 that do not contain catechin or tocopherol in the water-soluble antioxidant emulsions are used, it can be confirmed that the antioxidant effect of the water-soluble emulsion composition containing alkaloids is low. there was.
실험예 2: 수용해도 확인 Experimental Example 2: Confirmation of water solubility
상기 표 8 및 표 11에 기재된 조성에 따라 엑다이손 유화물에 수용성 항산화제 유화물을 투입한 후 유화액의 성상을 확인하면서 500 rpm 이하에서 혼합 분산 작업을 진행하여 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물을 제조하였다. After adding the water-soluble antioxidant emulsion to the ecdysone emulsion according to the compositions shown in Tables 8 and 11, mixing and dispersing at 500 rpm or less while confirming the properties of the emulsion is performed to perform a water-soluble antioxidant emulsion-containing alkaloid-containing water-soluble An emulsion composition was prepared.
제조된 알칼로이드 함유 수용성 유화 조성물의 수용해도를 아래와 같이 확인하였다. 증류수 50 ml를 항온수조에서 수온 38 ℃를 유지하고, 100 rpm 속도를 유지하면서 실시예와 비교예의 유화 조성물을 1g을 투입하였다. 1시간 후 원심분리 후 여과한 다음 Karl Fisher method 로 수분함량 측정하여 유기물 함량 정량하였다. The aqueous solubility of the prepared alkaloid-containing water-soluble emulsion composition was confirmed as follows. 1 g of the emulsion compositions of Examples and Comparative Examples were added while maintaining 50 ml of distilled water at a water temperature of 38° C. in a constant temperature water bath and maintaining a speed of 100 rpm. After 1 hour, centrifugation was followed by filtration, and the water content was measured by Karl Fisher method to quantify the organic matter content.
(중량%)division
(weight%)
1Example
One
33comparative example
33
34comparative example
34
35comparative example
35
(1wt%)Preparation Example 1
(1wt%)
(1wt%)Preparation Example 1
(1wt%)
(1wt%)Preparation Example 1
(1wt%)
(1wt%)Preparation Example 1
(1wt%)
(1wt%)Preparation Example 1
(1wt%)
(1wt%)Preparation Example 1
(1wt%)
(1wt%)Preparation 2
(1wt%)
(1wt%)Preparation 5
(1wt%)
유화물piperine
emulsion
(99wt%)Preparation 9
(99wt%)
(99wt%)Preparation 10
(99wt%)
(99wt%)Preparation 11
(99wt%)
(99wt%)Preparation 12
(99wt%)
(99wt%)Preparation 13
(99wt%)
(99wt%)Preparation 14
(99wt%)
(99wt%)Preparation 9
(99wt%)
(99wt%)Preparation 9
(99wt%)
(중량%)division
(weight%)
40comparative example
40
41comparative example
41
42comparative example
42
(1wt%)Preparation 6
(1wt%)
(1wt%)Preparation 7
(1wt%)
8
(1wt%)production example
8
(1wt%)
(99wt%)Preparation 9
(99wt%)
(99wt%)Preparation 9
(99wt%)
(99wt%)Preparation 9
(99wt%)
(중량%)division
(weight%)
3Example
3
43comparative example
43
44comparative example
44
45comparative example
45
(1wt%)Preparation Example 1
(1wt%)
(1wt%)Preparation Example 1
(1wt%)
(1wt%)Preparation Example 1
(1wt%)
(1wt%)Preparation Example 1
(1wt%)
(1wt%)Preparation Example 1
(1wt%)
(1wt%)Preparation Example 1
(1wt%)
(1wt%)Preparation 2
(1wt%)
(1wt%)Preparation 5
(1wt%)
(99wt%)Preparation 15
(99wt%)
(99wt%)Preparation 16
(99wt%)
(99wt%)Preparation 17
(99wt%)
(99wt%)Preparation 18
(99wt%)
(99wt%)Preparation 19
(99wt%)
(99wt%)Preparation 20
(99wt%)
(99wt%)Preparation 15
(99wt%)
(99wt%)Preparation 15
(99wt%)
(중량%)division
(weight%)
50comparative example
50
51comparative example
51
52comparative example
52
(1wt%)Preparation 6
(1wt%)
(1wt%)Preparation 7
(1wt%)
(1wt%)Preparation 8
(1wt%)
(99wt%)Preparation 15
(99wt%)
(99wt%)Preparation 15
(99wt%)
(99wt%)Preparation 15
(99wt%)
division
예 35compare
Example 35
division
division
(%)water solubility
(%)
상기 표 12 내지 표 14에 나타낸 바와 같이, HLB(Hydrophile-Lipophile Balance)가 상이한 2종의 계면활성제를 포함하는 수용성 항산화 유화물과 알칼로이드 유화물을 사용한 실시예 1 내지 15의 조성물은 비교예의 유화물과 비교하여 수용해도가 매우 높은 것으로 나타났다. As shown in Tables 12 to 14, the compositions of Examples 1 to 15 using a water-soluble antioxidant emulsion and an alkaloid emulsion containing two surfactants having different HLB (Hydrophile-Lipophile Balance) were compared with the emulsions of Comparative Examples. The water solubility was found to be very high.
실험예 3: 수분산 유화 입자 확인Experimental Example 3: Confirmation of water-dispersed emulsified particles
상기 표 8 및 표 11에 따라 제조된 알칼로이드 함유 수용성 유화 조성물의 유화 입자 크기를 아래와 같이 확인하였다. 증류수 50 ml를 항온수조에서 수온 38 ℃를 유지하고, 100 rpm 속도를 유지하면서 실시예와 비교예의 유화 조성물을 1g을 투입하였다. 1시간 후 광학현미경으로 유화 입자를 관찰하고 그 결과를 도 1 및 도 2에 나타내었다. The emulsified particle size of the alkaloid-containing water-soluble emulsion composition prepared according to Tables 8 and 11 was confirmed as follows. 1 g of the emulsion compositions of Examples and Comparative Examples were added while maintaining 50 ml of distilled water at a water temperature of 38° C. in a constant temperature water bath and maintaining a speed of 100 rpm. After 1 hour, the emulsified particles were observed under an optical microscope, and the results are shown in FIGS. 1 and 2 .
Zetasizer Nano ZS(Malvern Instrument, U.K.)를 사용하여 상기 증류수 중 유화입자의 크기를 측정하였다. 이때 시료에 대하여 3회 반복 측정하였고, 그 평균값을 하기 표 15에 나타내었다. The size of the emulsified particles in the distilled water was measured using a Zetasizer Nano ZS (Malvern Instrument, U.K.). At this time, the sample was repeatedly measured three times, and the average value is shown in Table 15 below.
division
1Example
One
3Example
3
(μm)Emulsion particle size
(μm)
상기 표 15, 도 1 및 도 2를 참조하면, 본 발명의 일 실시예에 해당하는 알칼로이드 함유 수용성 유화 조성물은 1.0 내지 5.0 μm의 유화 입자를 형성하는 반면, 비교예 33 내지 52의 알칼로이드 함유 수용성 유화 조성물은 유화 입자가 형성되지 않아 유화입자의 크기를 측정할 수 없었다. 이로부터 본 발명에 따른 알칼로이드 함유 수용성 유화 조성물은 생체에서 흡수되어 높은 생체이용률을 나타낼 수 있을 것으로 예상할 수 있다. Referring to Table 15, FIGS. 1 and 2, the alkaloid-containing water-soluble emulsion composition according to an embodiment of the present invention forms emulsified particles of 1.0 to 5.0 μm, while the alkaloid-containing water-soluble emulsion composition of Comparative Examples 33 to 52 The composition did not form emulsified particles, so the size of the emulsified particles could not be measured. From this, it can be expected that the alkaloid-containing water-soluble emulsion composition according to the present invention can be absorbed in the body and exhibit high bioavailability.
Claims (7)
토코페롤 1 내지 40 중량%,
카테킨 1 내지 40 중량%,
HLB 3 내지 HLB 7의 제1 계면활성제 1 내지 30 중량%,
HLB 10 내지 HLB 14의 제2 계면활성제 10 내지 80 중량%;
공계면활성제 10 내지 45 중량%, 및
식용 유지 1 내지 35 중량%,
(2) 전체 100 중량%를 만족하도록 하기 성분을 포함하는 알칼로이드 유화물:
알칼로이드 1 내지 30 중량%,
HLB 3 내지 HLB 7의 제1 계면활성제 1 내지 10 중량%,
HLB 10 내지 HLB 14의 제2 계면활성제 1 내지 20 중량%, 및
공계면활성제 40 내지 97 중량%,
를 포함하는, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.(1) A water-soluble antioxidant emulsion comprising the following ingredients to satisfy 100% by weight of the total:
1 to 40% by weight of tocopherol,
1 to 40% by weight of catechin,
1 to 30% by weight of a first surfactant of HLB 3 to HLB 7,
10 to 80% by weight of a second surfactant of HLB 10 to HLB 14;
10 to 45% by weight of a cosurfactant, and
1 to 35% by weight of edible oil,
(2) an alkaloid emulsion comprising the following components to satisfy the total 100% by weight:
1 to 30% by weight of an alkaloid;
1 to 10% by weight of a first surfactant of HLB 3 to HLB 7,
1 to 20% by weight of a second surfactant of HLB 10 to HLB 14, and
40 to 97% by weight of co-surfactant,
An alkaloid-containing water-soluble emulsion composition comprising a water-soluble antioxidant emulsion.
상기 수용성 항산화제 유화물 0.1 내지 20 중량%; 및
상기 알칼로이드 유화물 80 내지 99.9 중량%
를 포함하는 것인, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.The method of claim 1, wherein the alkaloid-containing water-soluble emulsion composition is
0.1 to 20% by weight of the water-soluble antioxidant emulsion; and
80 to 99.9 wt% of the alkaloid emulsion
A water-soluble emulsion composition containing an alkaloid containing a water-soluble antioxidant emulsion comprising a.
피페린, 캡사이신, 및 이들의 혼합물로 이루어진 군에서 선택된 1종인 것인, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.3. The method of claim 1 or 2, wherein the alkaloid is
An alkaloid-containing water-soluble emulsion composition containing a water-soluble antioxidant emulsion, which is one selected from the group consisting of piperine, capsaicin, and mixtures thereof.
글리세린 지방산 에스테르, 폴리글리세린 지방산 에스테르, 솔비탄 지방 에스테르, 레시틴, 프로필렌글리콜 지방산 에스테르 및 이들의 혼합물로 이루어진 군에서 선택된 1종인 것인, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.The method of claim 1 or 2, wherein the first surfactant is
An alkaloid-containing water-soluble emulsion composition containing a water-soluble antioxidant emulsion, which is one selected from the group consisting of glycerin fatty acid ester, polyglycerin fatty acid ester, sorbitan fatty ester, lecithin, propylene glycol fatty acid ester, and mixtures thereof.
폴리글리세린 지방산 에스테르, 폴리옥시에틸렌 솔비탄 지방산 에스테르, 자당 지방산 에스테르, 효소분해 레시틴 및 이들의 혼합물로 이루어진 군에서 선택된 1종인 것인, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.The method of claim 1 or 2, wherein the second surfactant is
An alkaloid-containing water-soluble emulsion composition containing a water-soluble antioxidant emulsion, which is one selected from the group consisting of polyglycerol fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, enzymatically decomposed lecithin, and mixtures thereof.
글리세린, 솔비톨, 폴리에틸렌글리콜, 프로필렌글리콜, 트리아세틴 및 이들의 혼합물로 이루어진 군에서 선택된 1종인 것인, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.The method of claim 1 or 2, wherein the co-surfactant is
An alkaloid-containing water-soluble emulsion composition containing a water-soluble antioxidant emulsion, which is one selected from the group consisting of glycerin, sorbitol, polyethylene glycol, propylene glycol, triacetin, and mixtures thereof.
두유, 옥수수유, 채종유, 고올레산 채종유, 홍화유, 미강유, 팜유, 올리브유, 해바라기유, 야자유, 소맥 배아유, 중쇄중성지방(MCT Oil)에서 선택된 1종 이상의 식용 유지인 것인, 수용성 항산화제 유화물을 함유하는 알칼로이드 함유 수용성 유화 조성물.The method of claim 1 or 2, wherein the edible oil is
Soymilk, corn oil, rapeseed oil, high oleic rapeseed oil, safflower oil, rice bran oil, palm oil, olive oil, sunflower oil, palm oil, wheat germ oil, and at least one edible oil selected from medium chain neutral fat (MCT Oil), water-soluble antioxidant emulsion An alkaloid-containing water-soluble emulsion composition containing
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210026166A KR20220122840A (en) | 2021-02-26 | 2021-02-26 | Water-soluble emulsion composition comprising alkaloids |
PCT/KR2021/018432 WO2022131656A1 (en) | 2020-12-15 | 2021-12-07 | Alkaloid-containing, water-soluble emulsified composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210026166A KR20220122840A (en) | 2021-02-26 | 2021-02-26 | Water-soluble emulsion composition comprising alkaloids |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220122840A true KR20220122840A (en) | 2022-09-05 |
Family
ID=83279766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210026166A KR20220122840A (en) | 2020-12-15 | 2021-02-26 | Water-soluble emulsion composition comprising alkaloids |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20220122840A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116850084A (en) * | 2023-07-11 | 2023-10-10 | 深圳杉海创新技术有限公司 | Surface-coated hydroxy pinacolin retinoic acid ester, preparation method, application and composition containing hydroxy pinacolin retinoic acid ester |
-
2021
- 2021-02-26 KR KR1020210026166A patent/KR20220122840A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116850084A (en) * | 2023-07-11 | 2023-10-10 | 深圳杉海创新技术有限公司 | Surface-coated hydroxy pinacolin retinoic acid ester, preparation method, application and composition containing hydroxy pinacolin retinoic acid ester |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240091192A1 (en) | Dilutable formulations of cannabinoids and processes for their preparation | |
KR102569534B1 (en) | Method for Selective Extraction of Cannabinoids from Plant Sources | |
Di Mattia et al. | Surface properties of phenolic compounds and their influence on the dispersion degree and oxidative stability of olive oil O/W emulsions | |
AU2008329540B2 (en) | Nanoemulsions | |
WO2018061011A1 (en) | Method for extraction of an agent from a plant source | |
DE102005031467A1 (en) | Emulsifier system, emulsion and their use | |
KR20220122840A (en) | Water-soluble emulsion composition comprising alkaloids | |
US20220117890A1 (en) | Cannabinoid emulsions | |
KR102583074B1 (en) | Water-soluble emulsion composition comprising natural polyphenolic compound | |
EP1848407A2 (en) | Oral pharmaceutical composition | |
KR102524312B1 (en) | Water-soluble emulsion composition comprising ecdysteroid | |
EP4265127A1 (en) | Water-soluble emulsion composition containing natural polyphenol compound | |
WO2022131656A1 (en) | Alkaloid-containing, water-soluble emulsified composition | |
JP2006249078A (en) | Emulsion drug formulation containing vegetable ingredient and its production method | |
Nikkhah et al. | Physical stability of microliposomes in bene (Pistacia atlantica) oil with different formulations | |
JP6622950B1 (en) | Compositions for preparing microemulsions, microemulsions, methods for their production and use of microemulsions | |
JPH10212477A (en) | Prevention of oxidation of o/w type emulsion, antioxidant composition and w/o type emulsion | |
KR100876308B1 (en) | Manufacturing method of water-soluble tocopherol emulsion | |
JPH10212478A (en) | Antioxidant composition for o/w type emulsion and o/w type emulsion | |
JP2021011467A (en) | Microemulsion and use of microemulsion | |
CN109248144B (en) | Transparent lipid emulsion | |
KR20180043699A (en) | Mischell emulsionized tocopherol composition and manufacturing method thereof | |
JPH10204093A (en) | Phospholipid composition, production of the composition and its use | |
EP4026432A1 (en) | Oil/fat composition | |
Nikkhah et al. | RESEARCH ARTICLE Physical stability of microliposomes in bene (Pistacia atlantica) oil with different formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |